MLTX: MoonLake Immunotherapeutics - Class A

Новости MLTX

• Investing 17:12 Guggenheim reiterates Buy rating on Moonlake Immunotherapeutics stock
• Benzinga 18:08 Merck's Keytruda Secures FDA Nod For Head And Neck Cancer As First Immunotherapy For Use Around Surgery - Merck & Co (NYSE:MRK)
• Seeking Alpha 19:08 MoonLake Immunotherapeutics: More Sonelokimab Success, With Big Pharma Interest (MLTX)
• Benzinga 15:02 Signet Posts Upbeat Earnings, Joins Ferguson Enterprises, Dollar General And Other Big Stocks Moving Higher On Tuesday - Credo Technology Group (NASDAQ:CRDO), Algonquin Power (NYSE:AQN)
• Investing 14:18 RBC Capital maintains outperform rating on Moonlake stock
• Investor's Business Daily 13:27 MoonLake Immunotherapeutics Catapults On Rumored $3 Billion Merck Takeover Bid
• Benzinga 11:38 Merck's Dealmaking Intensifies With MoonLake Bid As Keytruda Patent Cliff Nears: Report - MoonLake (NASDAQ:MLTX), Merck & Co (NYSE:MRK)
• Investing 10:40 Guggenheim reaffirms Buy rating on Moonlake stock amid M&A talks
• Benzinga 10:30 Why Credo Technology Group Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket - Agenus (NASDAQ:AGEN), Bumble (NASDAQ:BMBL)
• Reuters 21:31 Merck held talks to buy biotech MoonLake for over $3 billion, FT reports
• Investing 21:29 MoonLake Immunotherapeutics stock surges on FT report of Merck buyout talks
• Investing 21:08 Merck held talks to buy biotech MoonLake for over $3 billion, FT reports
• Investing 11:30 H.C. Wainwright maintains $100 target on Moonlake stock
• Investing 15:17 Wolfe Research lifts Moonlake stock to Outperform
• Seeking Alpha 07:31 MoonLake Immunotherapeutics: A Buy At Dips (NASDAQ:MLTX)
• Benzinga 15:36 This West Pharmaceutical Services Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Bloom Energy (NYSE:BE), Alpha Cognition (NASDAQ:ACOG)